Sunshine Biopharma Inc.

02/15/2022 | Press release | Archived content

SUNSHINE BIOPHARMA INC. ANNOUNCES PRICING OF $8 MILLION PUBLIC OFFERING AND UPLISTING TO THE NASDAQ CAPITAL MARKET